SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.25-2.9%2:19 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: E.J. Neitz Jr who wrote (6347)5/25/1998 10:02:00 PM
From: aknahow  Read Replies (2) of 17367
 
Tyco friendly pooling of interest with U. S. Surgical in $3.3 billion exchange of stock is not exactly a biotech nor drug merger nor it is the magnitude of the rumored Amgen buyout, but it was announced yesterday and IMO calls attention to the overall medical sector. Not only will some of holders redeploy to other companies in this sector but those that are thinking about acquisitions have one more reason to intensify their activities.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext